Advertisement

Topics

NexGenix Pharmaceuticals Holdings, Inc. Company Profile

04:43 EST 25th November 2017 | BioPortfolio

NexGenix Pharmaceuticals was formed to pursue recent major advances in genetic and signal transduction research for the benefit of patients with neurofibromatosis. By concentrating much of the world's basic science and clinical expertise on NF in one company we are accelerating treatments to patients. NexGenix is the first and only company to focus on NF.

Location

152 West 57th StreetSuite 11B
New York
New York
10019
United States of America

Contact

Phone: (212) 974-3006
Fax: (212) 974-1042
Email: info@nexgenixpharm.com


News Articles [752 Associated News Articles listed on BioPortfolio]

Comparing Parnell Pharmaceuticals Holdings

Parnell Pharmaceuticals Holdings and Mylan N.V. are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst reco...

Analyzing Parnell Pharmaceuticals Holdings

Parnell Pharmaceuticals Holdings and Mylan are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitabiliy, dividends, ...

Achillion Pharmaceuticals, Inc. (ACHN) Holdings Reduced by Alliancebernstein L.P.

Alliancebernstein L.P. trimmed its holdings in shares of Achillion Pharmaceuticals, Inc. by 6.7% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exch...

Achillion Pharmaceuticals, Inc. (ACHN) Holdings Reduced by Pacad Investment Ltd.

Pacad Investment Ltd. trimmed its holdings in shares of Achillion Pharmaceuticals, Inc. by 64.3% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exch...

Head-To-Head Contrast: Kadmon Holdings

Kadmon Holdings and Alexion Pharmaceuticals are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst reco...

Deals this week: Milestone Pharmaceuticals, Homology Medicines, Ultragenyx Pharmaceutical

Canadian cardiovascular drug development company Milestone Pharmaceuticals has secured $55m through a series C funding round led by Novo Holdings.

Capha Pharmaceuticals Not Proceeding With Acquisition of AgriForest Bio-Technologies Ltd.

WEST KELOWNA, BC--(Marketwired - July 05, 2017) - Capha Pharmaceuticals Inc. ("Capha" and/or the "Company") has terminated the Letter of Intent ("LOI") with Patel Holdings Ltd. previously announced o...

Pernix sells SI Pharmaceuticals its Cedax for $2mm

SI Pharmaceuticals LLC acquired Pernix Therapeutics Holdings Inc.'s third-generation cephalosporin antibiotic Cedax (ceftibuten) capsules and oral suspension for $2mm.

PubMed Articles [126 Associated PubMed Articles listed on BioPortfolio]

Announcing the 2017 Pharmaceuticals Travel Award for Young Post-Doctoral Researchers.

Last year, for the first time in its history, our Journal was able to offer a travel grant of 800 CHF to a young researcher in the field of medicinal chemistry.

Suspended solids moderate the degradation and sorption of waste water-derived pharmaceuticals in estuarine waters.

This study focuses on the fate of pharmaceuticals discharged into an estuarine environment, particularly into the Turbidity Maximum Zone (TMZ). Batch experiments were set up to investigate the factors...

Chiral pharmaceuticals: A review on their environmental occurrence and fate processes.

More than 50% of pharmaceuticals in current use are chiral compounds. Enantiomers of the same pharmaceutical have identical physicochemical properties, but may exhibit differences in pharmacokinetics,...

Comparative study on pharmaceuticals adsorption in reclaimed water desalination concentrate using biochar: Impact of salts and organic matter.

The synergistic impact of salts and organic matter on adsorption of ibuprofen and sulfamethoxazole by three types of biochar and an activated carbon was investigated using reclaimed water reverse osmo...

Effects of exposure to pharmaceuticals (diclofenac and carbamazepine) spiked sediments in the midge, Chironomus riparius (Diptera, Chironomidae).

Human and veterinary pharmaceuticals and degradation products are continuously introduced into the environment. To date, there is a lack of information about the effects of pharmaceuticals in spiked t...

Clinical Trials [208 Associated Clinical Trials listed on BioPortfolio]

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects Under Fasting Condition

- Objective: - To compare the rate and extent of absorption of Citalopram Hydrobromide Tablets 40 mg: Test Product: Citalopram Hydrobromide Tablets 40 mg manufactured b...

Bioequivalence Study of Hydrochlorothiazide 50mg Tablets Under Fasting Conditions

To compare the single-dose oral bioavailability of hydrochlorothiazide 50 mg tablet of Ohm Laboratories (A subsidiary of Ranbaxy pharmaceuticals USA) with hydrochlorothiazide 50 mg tablet ...

Companies [1692 Associated Companies listed on BioPortfolio]

NexGenix Pharmaceuticals Holdings, Inc.

NexGenix Pharmaceuticals was formed to pursue recent major advances in genetic and signal transduction research for the benefit of patients with neurofibromatosis. By concentrating much of the world's...

Predix Pharmaceuticals Holdings, Inc.

Predix Pharmaceuticals Holdings, Inc. is a pharmaceutical company focused on the discovery and development of novel, highly selective, small-molecule drugs that target G-Protein Coupled Receptors (GPC...

Endo Pharmaceuticals Holdings Inc.

Endo Pharmaceuticals Holdings

Integra Holdings

Founded by Yissum, Integra Holdings is a unique venture fund, focusing on an exclusive selection of biotech companies with proprietary solutions and a competitive advantage in the...

More Information about "NexGenix Pharmaceuticals Holdings, Inc." on BioPortfolio

We have published hundreds of NexGenix Pharmaceuticals Holdings, Inc. news stories on BioPortfolio along with dozens of NexGenix Pharmaceuticals Holdings, Inc. Clinical Trials and PubMed Articles about NexGenix Pharmaceuticals Holdings, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NexGenix Pharmaceuticals Holdings, Inc. Companies in our database. You can also find out about relevant NexGenix Pharmaceuticals Holdings, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record